Aurdan Capital Management LLC Has $669,000 Stake in CVS Health Corporation $CVS

Aurdan Capital Management LLC reduced its holdings in CVS Health Corporation (NYSE:CVS) by 8.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 9,700 shares of the pharmacy operator’s stock after selling 940 shares during the quarter. Aurdan Capital Management LLC’s holdings in CVS Health were worth $669,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CVS. Avion Wealth grew its holdings in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the second quarter valued at approximately $30,000. Bell Investment Advisors Inc grew its stake in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC increased its position in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC raised its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 1.9%

NYSE CVS opened at $78.13 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15. The company has a market capitalization of $99.18 billion, a price-to-earnings ratio of 205.61, a PEG ratio of 0.87 and a beta of 0.60. The stock’s 50 day moving average is $76.49 and its two-hundred day moving average is $69.04. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter last year, the company earned $1.09 EPS. CVS Health’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is currently 700.00%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Royal Bank Of Canada raised their price target on shares of CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday. Piper Sandler lifted their target price on CVS Health from $81.00 to $99.00 in a research report on Friday. Sanford C. Bernstein upped their price target on CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Wells Fargo & Company raised their price objective on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.64.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.